[go: up one dir, main page]

HRP20050933A2 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
HRP20050933A2
HRP20050933A2 HR20050933A HRP20050933A HRP20050933A2 HR P20050933 A2 HRP20050933 A2 HR P20050933A2 HR 20050933 A HR20050933 A HR 20050933A HR P20050933 A HRP20050933 A HR P20050933A HR P20050933 A2 HRP20050933 A2 HR P20050933A2
Authority
HR
Croatia
Prior art keywords
organic compounds
compounds
zwitterions
muscarinic
receptor
Prior art date
Application number
HR20050933A
Other languages
English (en)
Croatian (hr)
Inventor
Paul Collingwood Stephen
Cox Brian
Baettig Urs
Bhalay Gurdip
James Devereux Nicholas
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20050933(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0324887A external-priority patent/GB0324887D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HRP20050933A2 publication Critical patent/HRP20050933A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20050933A 2003-05-02 2004-04-30 Organic compounds HRP20050933A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0310232 2003-05-02
GB0324887A GB0324887D0 (en) 2003-10-24 2003-10-24 Organic compounds
PCT/EP2004/004605 WO2004096800A2 (en) 2003-05-02 2004-04-30 Quinuclidine derivatives binding to mucarinic m3 receptors

Publications (1)

Publication Number Publication Date
HRP20050933A2 true HRP20050933A2 (en) 2006-12-31

Family

ID=33420896

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050933A HRP20050933A2 (en) 2003-05-02 2004-04-30 Organic compounds

Country Status (31)

Country Link
US (2) US20070060563A1 (no)
EP (1) EP1631569B1 (no)
JP (1) JP4416786B2 (no)
KR (1) KR100896544B1 (no)
AR (1) AR044134A1 (no)
AT (1) ATE440840T1 (no)
AU (1) AU2004234069B2 (no)
BR (1) BRPI0410238A (no)
CA (1) CA2523436C (no)
CL (1) CL2004000918A1 (no)
CO (1) CO5700782A2 (no)
CY (1) CY1109655T1 (no)
DE (1) DE602004022805D1 (no)
DK (1) DK1631569T3 (no)
EC (1) ECSP056134A (no)
ES (1) ES2331185T3 (no)
HR (1) HRP20050933A2 (no)
IL (1) IL171591A (no)
IS (1) IS2746B (no)
MA (1) MA27775A1 (no)
MX (1) MXPA05011739A (no)
MY (1) MY142652A (no)
NO (1) NO20055688L (no)
NZ (1) NZ542995A (no)
PE (1) PE20050465A1 (no)
PL (1) PL1631569T3 (no)
PT (1) PT1631569E (no)
RU (1) RU2363700C2 (no)
SI (1) SI1631569T1 (no)
TW (1) TWI340139B (no)
WO (1) WO2004096800A2 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239546B1 (es) * 2004-03-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos esteres de quinuclidina cuaternizados.
GB0410712D0 (en) 2004-05-13 2004-06-16 Novartis Ag Organic compounds
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0428416D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP1900737A1 (en) * 2006-08-31 2008-03-19 Novartis AG Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
EP1894568A1 (en) * 2006-08-31 2008-03-05 Novartis AG Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
RU2009120229A (ru) * 2006-12-19 2011-01-27 Астразенека Аб (Se) Производные хинуклидинола в качестве антагонистов мускариновых рецепторов
EP1950196A1 (de) * 2007-01-29 2008-07-30 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Ammoniumhexafluorophosphaten
ATE531692T1 (de) 2007-09-07 2011-11-15 Theravance Inc Als antagonisten am muskarinrezeptor geeignete guanidinhaltige verbindungen
WO2009079392A1 (en) 2007-12-14 2009-06-25 Theravance, Inc. Amidine-containing compounds useful as muscarinic receptor antagonists
AU2009203693B2 (en) 2008-01-11 2012-06-07 Novartis Ag Pyrimidines as kinase inhibitors
GB0808709D0 (en) * 2008-05-13 2008-06-18 Astrazeneca Ab New combination 295
JP4837800B2 (ja) * 2008-05-13 2011-12-14 アストラゼネカ・アクチエボラーグ ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
JP2011520877A (ja) * 2008-05-13 2011-07-21 アストラゼネカ・アクチエボラーグ ムスカリン受容体アンタゴニストおよびβ２−アドレナリン受容体アゴニストを含む医薬品
US20090326004A1 (en) 2008-06-03 2009-12-31 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
GB0811100D0 (en) * 2008-06-17 2008-07-23 Astrazeneca Ab New combination
WO2009153536A1 (en) * 2008-06-17 2009-12-23 Argenta Discovery Limited 1-aza-bicyclo [2.2.2] octane derivatives useful as muscarinic receptor antagonists
BR112012032332A2 (pt) * 2010-06-22 2016-11-08 Chiesi Farma Spa composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
MX2013009767A (es) 2011-02-25 2013-10-01 Irm Llc Compuestos y composiciones como inhibidores de trk.
JP2011195593A (ja) * 2011-06-30 2011-10-06 Astrazeneca Ab ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
CA2862008A1 (en) * 2011-12-30 2013-07-04 Chiesi Farmaceutici S.P.A. Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof
CA2871926A1 (en) 2012-05-03 2013-11-07 Saint Louis College Of Pharmacy Compositions and methods for increasing neurotrophic peptides
TWI647227B (zh) * 2013-02-28 2019-01-11 日商安斯泰來製藥股份有限公司 ２－醯胺噻唑衍生物或其鹽
CZ306791B6 (cs) 2013-10-29 2017-07-12 Zentiva, K.S. Průmyslově využitelný způsob přípravy aklidinium bromidu o vysoké čistotě
PT108370B (pt) * 2015-03-30 2018-10-25 Hovione Farm S A Processo de preparação de brometo de aclidínio
EP3111978B1 (en) 2015-07-03 2021-09-01 Novartis AG Inhaler adapted to read information stored in a data storage means of a container

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
DK534178A (da) * 1977-12-16 1979-06-17 Interx Research Corp Anticholinerge midler med sektrtionshaemmende virkning
IT1230881B (it) * 1989-06-20 1991-11-08 Angeli Inst Spa Derivati del r(-) 3-chinuclidinolo
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP1302458A4 (en) * 2000-07-11 2005-10-19 Banyu Pharma Co Ltd ESTER DERIVATIVES
AU2002238471B2 (en) * 2000-12-28 2007-06-28 Almirall, S.A. Quinuclidine derivatives and their use as M3 antagonists
PL211250B1 (pl) * 2001-12-20 2012-04-30 Chiesi Farma Spa Pochodne karbaminianu 1-alkilo-1-azoniabicyklo [2.2.2] oktanu, jej zastosowania, kompozycja farmaceutyczna zawierająca ten związek oraz związek pośredni
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
EP1900737A1 (en) * 2006-08-31 2008-03-19 Novartis AG Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide

Also Published As

Publication number Publication date
CA2523436C (en) 2011-11-01
EP1631569A2 (en) 2006-03-08
JP2006525267A (ja) 2006-11-09
WO2004096800A3 (en) 2005-01-06
MA27775A1 (fr) 2006-02-01
AR044134A1 (es) 2005-08-24
JP4416786B2 (ja) 2010-02-17
WO2004096800A2 (en) 2004-11-11
TW200505920A (en) 2005-02-16
IS8158A (is) 2005-11-30
ECSP056134A (es) 2006-04-19
KR20060015572A (ko) 2006-02-17
NO20055688L (no) 2006-01-09
EP1631569B1 (en) 2009-08-26
RU2363700C2 (ru) 2009-08-10
AU2004234069B2 (en) 2008-02-21
PL1631569T3 (pl) 2010-02-26
US8168654B2 (en) 2012-05-01
US20100041887A1 (en) 2010-02-18
AU2004234069A1 (en) 2004-11-11
MY142652A (en) 2010-12-15
IL171591A (en) 2010-11-30
CY1109655T1 (el) 2014-08-13
PT1631569E (pt) 2009-11-26
RU2005137360A (ru) 2006-07-27
MXPA05011739A (es) 2006-01-26
NO20055688D0 (no) 2005-12-01
DK1631569T3 (da) 2009-11-23
CO5700782A2 (es) 2006-11-30
CL2004000918A1 (es) 2005-02-11
ES2331185T3 (es) 2009-12-23
HK1087704A1 (en) 2006-10-20
US20070060563A1 (en) 2007-03-15
DE602004022805D1 (de) 2009-10-08
IS2746B (is) 2011-08-15
PE20050465A1 (es) 2005-07-18
NZ542995A (en) 2009-02-28
BRPI0410238A (pt) 2006-05-16
CA2523436A1 (en) 2004-11-11
ATE440840T1 (de) 2009-09-15
KR100896544B1 (ko) 2009-05-07
SI1631569T1 (sl) 2010-01-29
TWI340139B (en) 2011-04-11

Similar Documents

Publication Publication Date Title
HRP20050933A2 (en) Organic compounds
DE602004011199D1 (de) 5-phenylthiazolderivate und deren verwendung als p13-kinase-inhibitoren
ES2368594T3 (es) Derivados sustituidos de ciclohexilmetilo.
ECSP055676A (es) Piperazinas heterocíclicas sustituidas para el tratamiento de la esquizofrenia
TW200519106A (en) Organic compounds
SE0401971D0 (sv) Piperidne derivatives
MEP36508A (en) Triazolopyrazine derivatives useful as anti-cancer agents
BRPI0406762A (pt) Derivados de n-(1-benzil-2-oxo-2-(1-piperazinil)etil)-1-piperidincarb oxamida e compostos relacionados como antagonistas de cgrp, para tratamento de dores de cabeça
CY1112960T1 (el) Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων
WO2007084595A3 (en) Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
NO20064238L (no) Imidazolinderivater med CB1 agonistlsk aktivitet
SE0403171D0 (sv) New compounds
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
SE0401970D0 (sv) Novel compounds
ATE449069T1 (de) Aminopropanolderivate
SE0302139D0 (sv) Novel compounds
WO2009055629A3 (en) Cyclohexeneamide derivatives and their use as trpv1 antagonist
SE0303541D0 (sv) New compounds
BRPI0519292A2 (pt) compostos orgÂnicos
MXPA05013823A (es) Derivados de pirrolidinio y piperidino como ligandos para el receptor m3 muscarinico.
ATE553095T1 (de) Neue imidazolderivate, deren herstellung und deren verwendung als intermediate zur herstellung von arzneimitteln und pestiziden
DE602004011204D1 (de) Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten.
ATE541839T1 (de) Pyrrolidiniumderivate als m3-muskarinische rezeptoren
ATE409179T1 (de) Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten
ATE543803T1 (de) 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20110423

Year of fee payment: 8

OBST Application withdrawn